1 / 5

Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 B

The acute lymphocytic leukemia therapeutics market was valued at $1.96 billion in 2010 and is expected to reach $3.88 billion by 2020, at a CAGR of 5.21% between 2015 and 2020. The market was dominated by Hyper-CVAD regimen in 2010. However, in 2020, the market is expected to be equally dominated by Hyper-CVAD and Linker regimen. The chemotherapy drug regimens were dominated by Hyper-CVAD regimen sales, totaling $1.8 billion and linker regimen sales totaling $1.13 billion sales in acute lymphocytic leukemia market.

david76
Download Presentation

Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 B

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Markets and Markets Acute Lymphocytic Leukemia Therapeutics Market ( 2020) http://www.marketsandmarkets.com/Market-Reports/acute-lymphocytic-leukemia-therapeutics-market-518.html

  2. INTRODUCTION • The market research report “Marketsandmarkets adds a new report“Acute Lymphocytic Leukemia Therapeutics Market (Pipeline Forecast & Market Forecast in G8 Countries) (2010- 2020)”has been published by MarketsandMarkets. According to this report studies The acute lymphocytic leukemia therapeutics market was valued at $1.96 billion in 2010 and is expected to reach $3.88 billion by 2020, at a CAGR of 5.21% between 2015 and 2020 • Browse>> • Browse market data tables and in-depth TOC on Acute Lymphocytic Leukemia Therapeutics Market • Request to Download Free PDF Brochure @

  3. Scope of Report • This research report categorizes the market in G8 countries into the following segments: • Acute Lymphocytic Leukemia TherapeuticsMarket, by Drug • Existing Regimens/Drugs • Hyper-CVAD Regimen • CALGB 8811 Regimen • Linker Regimen • Nucleoside Metabolic Inhibitors (Clolar and Nelarabine) • Oncaspar • Pipeline Drugs (Phase III) • Graspa • Marqibo • Inotuzumab Ozogamicin

  4. Acute Lymphocytic Leukemia Therapeutics Market

  5. About Marketsandmarkets: MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Get in touch with us at +1-888-6006-441 or send email to sales@marketsandmarkets.com with your contact details and questions if any query.

More Related